Global Brain Biomarker Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: G76BCE118E7AEN
QYResearch

Abstracts

This report focuses on the global Brain Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brain Biomarker development in North America, Europe and Asia-Pacific.
The key players covered in this study

• Philips
• Johnson & Johnson
• Roche
• Seimens
• GE
• NeuroVista
• Qiagen
• Lifesign
• Natus
• BrainScope

Market segment by Type, the product can be split into

• Biomarker Test Kits
• Biomarker Analyzers

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Brain Biomarker status, future forecast, growth opportunity, key market and key players.
• To present the Brain Biomarker development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Brain Biomarker are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Biomarker Revenue
1.4 Market Analysis by Type
  1.4.1 Global Brain Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Biomarker Test Kits
  1.4.3 Biomarker Analyzers
1.5 Market by Application
  1.5.1 Global Brain Biomarker Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Diagnostic Laboratories
1.6 Coronavirus Disease 2019 (Covid-19): Brain Biomarker Industry Impact
  1.6.1 How the Covid-19 is Affecting the Brain Biomarker Industry
    1.6.1.1 Brain Biomarker Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Brain Biomarker Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Brain Biomarker Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Brain Biomarker Market Perspective (2015-2026)
2.2 Brain Biomarker Growth Trends by Regions
  2.2.1 Brain Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Brain Biomarker Historic Market Share by Regions (2015-2020)
  2.2.3 Brain Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Brain Biomarker Market Growth Strategy
  2.3.6 Primary Interviews with Key Brain Biomarker Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Brain Biomarker Players by Market Size
  3.1.1 Global Top Brain Biomarker Players by Revenue (2015-2020)
  3.1.2 Global Brain Biomarker Revenue Market Share by Players (2015-2020)
  3.1.3 Global Brain Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Biomarker Market Concentration Ratio
  3.2.1 Global Brain Biomarker Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Brain Biomarker Revenue in 2019
3.3 Brain Biomarker Key Players Head office and Area Served
3.4 Key Players Brain Biomarker Product Solution and Service
3.5 Date of Enter into Brain Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Brain Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Brain Biomarker Forecasted Market Size by Type (2021-2026)

5 BRAIN BIOMARKER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Brain Biomarker Market Size by Application (2015-2020)
5.2 Global Brain Biomarker Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Brain Biomarker Market Size (2015-2020)
6.2 Brain Biomarker Key Players in North America (2019-2020)
6.3 North America Brain Biomarker Market Size by Type (2015-2020)
6.4 North America Brain Biomarker Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Brain Biomarker Market Size (2015-2020)
7.2 Brain Biomarker Key Players in Europe (2019-2020)
7.3 Europe Brain Biomarker Market Size by Type (2015-2020)
7.4 Europe Brain Biomarker Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Brain Biomarker Market Size (2015-2020)
8.2 Brain Biomarker Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Brain Biomarker Market Size by Type (2015-2020)
8.4 Asia-Pacific Brain Biomarker Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Philips
  9.1.1 Philips Company Details
  9.1.2 Philips Business Overview and Its Total Revenue
  9.1.3 Philips Brain Biomarker Introduction
  9.1.4 Philips Revenue in Brain Biomarker Business (2015-2020))
  9.1.5 Philips Recent Development
9.2 Johnson & Johnson
  9.2.1 Johnson & Johnson Company Details
  9.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.2.3 Johnson & Johnson Brain Biomarker Introduction
  9.2.4 Johnson & Johnson Revenue in Brain Biomarker Business (2015-2020)
  9.2.5 Johnson & Johnson Recent Development
9.3 Roche
  9.3.1 Roche Company Details
  9.3.2 Roche Business Overview and Its Total Revenue
  9.3.3 Roche Brain Biomarker Introduction
  9.3.4 Roche Revenue in Brain Biomarker Business (2015-2020)
  9.3.5 Roche Recent Development
9.4 Seimens
  9.4.1 Seimens Company Details
  9.4.2 Seimens Business Overview and Its Total Revenue
  9.4.3 Seimens Brain Biomarker Introduction
  9.4.4 Seimens Revenue in Brain Biomarker Business (2015-2020)
  9.4.5 Seimens Recent Development
9.5 GE
  9.5.1 GE Company Details
  9.5.2 GE Business Overview and Its Total Revenue
  9.5.3 GE Brain Biomarker Introduction
  9.5.4 GE Revenue in Brain Biomarker Business (2015-2020)
  9.5.5 GE Recent Development
9.6 NeuroVista
  9.6.1 NeuroVista Company Details
  9.6.2 NeuroVista Business Overview and Its Total Revenue
  9.6.3 NeuroVista Brain Biomarker Introduction
  9.6.4 NeuroVista Revenue in Brain Biomarker Business (2015-2020)
  9.6.5 NeuroVista Recent Development
9.7 Qiagen
  9.7.1 Qiagen Company Details
  9.7.2 Qiagen Business Overview and Its Total Revenue
  9.7.3 Qiagen Brain Biomarker Introduction
  9.7.4 Qiagen Revenue in Brain Biomarker Business (2015-2020)
  9.7.5 Qiagen Recent Development
9.8 Lifesign
  9.8.1 Lifesign Company Details
  9.8.2 Lifesign Business Overview and Its Total Revenue
  9.8.3 Lifesign Brain Biomarker Introduction
  9.8.4 Lifesign Revenue in Brain Biomarker Business (2015-2020)
  9.8.5 Lifesign Recent Development
9.9 Natus
  9.9.1 Natus Company Details
  9.9.2 Natus Business Overview and Its Total Revenue
  9.9.3 Natus Brain Biomarker Introduction
  9.9.4 Natus Revenue in Brain Biomarker Business (2015-2020)
  9.9.5 Natus Recent Development
9.10 BrainScope
  9.10.1 BrainScope Company Details
  9.10.2 BrainScope Business Overview and Its Total Revenue
  9.10.3 BrainScope Brain Biomarker Introduction
  9.10.4 BrainScope Revenue in Brain Biomarker Business (2015-2020)
  9.10.5 BrainScope Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Brain Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Brain Biomarker Revenue
Table 3. Ranking of Global Top Brain Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Brain Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biomarker Test Kits
Table 6. Key Players of Biomarker Analyzers
Table 7. COVID-19 Impact Global Market: (Four Brain Biomarker Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Brain Biomarker Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Brain Biomarker Players to Combat Covid-19 Impact
Table 12. Global Brain Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Brain Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Brain Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Brain Biomarker Market Share by Regions (2015-2020)
Table 16. Global Brain Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Brain Biomarker Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Brain Biomarker Market Growth Strategy
Table 22. Main Points Interviewed from Key Brain Biomarker Players
Table 23. Global Brain Biomarker Revenue by Players (2015-2020) (Million US$)
Table 24. Global Brain Biomarker Market Share by Players (2015-2020)
Table 25. Global Top Brain Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Biomarker as of 2019)
Table 26. Global Brain Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Brain Biomarker Product Solution and Service
Table 29. Date of Enter into Brain Biomarker Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Brain Biomarker Market Size by Type (2015-2020) (Million US$)
Table 32. Global Brain Biomarker Market Size Share by Type (2015-2020)
Table 33. Global Brain Biomarker Revenue Market Share by Type (2021-2026)
Table 34. Global Brain Biomarker Market Size Share by Application (2015-2020)
Table 35. Global Brain Biomarker Market Size by Application (2015-2020) (Million US$)
Table 36. Global Brain Biomarker Market Size Share by Application (2021-2026)
Table 37. North America Key Players Brain Biomarker Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Brain Biomarker Market Share (2019-2020)
Table 39. North America Brain Biomarker Market Size by Type (2015-2020) (Million US$)
Table 40. North America Brain Biomarker Market Share by Type (2015-2020)
Table 41. North America Brain Biomarker Market Size by Application (2015-2020) (Million US$)
Table 42. North America Brain Biomarker Market Share by Application (2015-2020)
Table 43. Europe Key Players Brain Biomarker Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Brain Biomarker Market Share (2019-2020)
Table 45. Europe Brain Biomarker Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Brain Biomarker Market Share by Type (2015-2020)
Table 47. Europe Brain Biomarker Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Brain Biomarker Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Brain Biomarker Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Brain Biomarker Market Share (2019-2020)
Table 51. Asia-Pacific Brain Biomarker Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Brain Biomarker Market Share by Type (2015-2020)
Table 53. Asia-Pacific Brain Biomarker Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Brain Biomarker Market Share by Application (2015-2020)
Table 55. Philips Company Details
Table 56. Philips Business Overview
Table 57. Philips Product
Table 58. Philips Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 59. Philips Recent Development
Table 60. Johnson & Johnson Company Details
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Product
Table 63. Johnson & Johnson Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 64. Johnson & Johnson Recent Development
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Product
Table 68. Roche Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 69. Roche Recent Development
Table 70. Seimens Company Details
Table 71. Seimens Business Overview
Table 72. Seimens Product
Table 73. Seimens Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 74. Seimens Recent Development
Table 75. GE Company Details
Table 76. GE Business Overview
Table 77. GE Product
Table 78. GE Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 79. GE Recent Development
Table 80. NeuroVista Company Details
Table 81. NeuroVista Business Overview
Table 82. NeuroVista Product
Table 83. NeuroVista Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 84. NeuroVista Recent Development
Table 85. Qiagen Company Details
Table 86. Qiagen Business Overview
Table 87. Qiagen Product
Table 88. Qiagen Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 89. Qiagen Recent Development
Table 90. Lifesign Business Overview
Table 91. Lifesign Product
Table 92. Lifesign Company Details
Table 93. Lifesign Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 94. Lifesign Recent Development
Table 95. Natus Company Details
Table 96. Natus Business Overview
Table 97. Natus Product
Table 98. Natus Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 99. Natus Recent Development
Table 100. BrainScope Company Details
Table 101. BrainScope Business Overview
Table 102. BrainScope Product
Table 103. BrainScope Revenue in Brain Biomarker Business (2015-2020) (Million US$)
Table 104. BrainScope Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Brain Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Biomarker Test Kits Features
Figure 3. Biomarker Analyzers Features
Figure 4. Global Brain Biomarker Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Brain Biomarker Report Years Considered
Figure 9. Global Brain Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Brain Biomarker Market Share by Regions: 2020 VS 2026
Figure 11. Global Brain Biomarker Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Brain Biomarker Market Share by Players in 2019
Figure 14. Global Top Brain Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Biomarker as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Brain Biomarker Revenue in 2019
Figure 16. North America Brain Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Brain Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Brain Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Philips Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 21. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Johnson & Johnson Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 23. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Roche Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 25. Seimens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Seimens Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 27. GE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GE Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 29. NeuroVista Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. NeuroVista Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 31. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Qiagen Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 33. Lifesign Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Lifesign Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 35. Natus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Natus Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 37. BrainScope Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. BrainScope Revenue Growth Rate in Brain Biomarker Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed